NAMSW
Financials
- Market Capitalization 3.8917 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 6419 |  AADI Aadi Bioscience Inc | 2.05 USD | 0.00% | 0.00% | -19.29% | -27.30% | 0 USD | ||
| 6552 |  RVMDW Revolution Medicines, Inc. - Warrant | 9.1399 USD | +1.89% | -6.59% | +47.42% | +4250.26% | 39.32 B USD | ||
| 6876 |  DRTSW Alpha Tau Medical Ltd. - Warrant | 3.4000 USD | +4.43% | +3.34% | +78.95% | +1378.26% | 1.09 B USD | ||
| 6958 |  XOMAO XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | 25.00 USD | 0.00% | +0.16% | -1.54% | -1.22% | 503.77 M USD |
Frequently asked questions about NewAmsterdam Pharma Company N.V. - Warrant
What is the NewAmsterdam Pharma Company N.V. - Warrant stock price today?
The current price of NewAmsterdam Pharma Company N.V. - Warrant (NAMSW) is 24.89. Over the past 24 hours, the stock has changed by 0.00%. Follow the NAMSW chart for real-time price dynamics.
What is the stock ticker of NewAmsterdam Pharma Company N.V. - Warrant?
NewAmsterdam Pharma Company N.V. - Warrant trades under the ticker NAMSW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NewAmsterdam Pharma Company N.V. - Warrant stock going up?
NAMSW has changed by +8.45% over the last week, +32.46% over the last month, and +169.66% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was NewAmsterdam Pharma Company N.V. - Warrant net income for the last quarter?
NewAmsterdam Pharma Company N.V. - Warrant reported net income of -48.44 M for the last quarter. The previous quarter showed -74.92 M, which means net income changed by +35.35%.
How many employees does NewAmsterdam Pharma Company N.V. - Warrant have?
As of the latest available data, NewAmsterdam Pharma Company N.V. - Warrant has 100 employees. Workforce size can provide additional context about the company's scale and operations.
What is NewAmsterdam Pharma Company N.V. - Warrant EBITDA?
NewAmsterdam Pharma Company N.V. - Warrant EBITDA is -65.93 M, and its EBITDA margin is -2 168.88%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NewAmsterdam Pharma Company N.V. - Warrant stock?
You can buy NewAmsterdam Pharma Company N.V. - Warrant (NAMSW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NewAmsterdam Pharma Company N.V. - Warrant stock?
Investing in NewAmsterdam Pharma Company N.V. - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NAMSW chart and related analysis on metatrader.com as part of your research.